Prof.Dr.Haruhiko Inufusa publication list

1. Iwasa, Z., Inufusa, H., Yamato, M., Takagi, H., Tanaka, A., Nakamura, T., Fukuhara, T., and Yasutomi, M. Immunohistochemical studies on estrogen receptor of scirrhus gastric cancer. Jpn J Gastroenterol Surg, 18, 1985.
2. Onishi, H., Inufusa, H., Kurooka, K., Haeno, Y., Iwasa, Z., and Yasutomi, M. A case report of duodenal obstruction due to rupture of superior pancreaticoduodenal artery aneurysm. Med J Kinki Univ, 10: 317-326, 1985.
3. Sagara, N., Inufusa, H., Haeno, Y., Kurooka, K., Hara, S., Nakai, T., Funai, S., Hida, J., Hirohata, k., Mori, N., Iwasa, Z., and Yasutomi, M. Measurement of a new tumor marker KM01-RPHA. Kisotorinsho, 19: 470-474, 1985.
4. Takagi, H., Inufusa, H., Tanaka, A., Nakamura, T., Hamada, H., Matsuda, T., Iwasa, Z., and Yasutomi, M. Three cases of the gastric cancer with acanthosis nigricans. Med J Kinki Univ, 10: 417-423, 1985.
5. Tanaka, A., Inufusa, H., Takagi, H., Hatta, M., Nakamura, T., Hamada, H., Izumoto, G., Iwasa, Z., and Yasutomi, M. Studies on lymph node metastasis of gastric cancer. Med J Kinki Univ, 10: 271-279, 1985.
6. Yasutomi, M., Inufusa, H., and Iwasa, Z. Suture and anastomosis of the digestive canal. Semin Gastroenterol Surg, 19: 251-265, 1985.
7. Inufusa, H., Sagara, N., Hara, S., Sakaguchi, T., Tkagi, H., Tanaka, A., Hamada, H., Okuno, K., Iwasa, Z., and Yasutomi, M. Establishment of nude mice serially transplantable human stomach cancer KUMMK-2 producing plural tumor marker. Jpn J Gastroenterol, 83: 2264, 1986.
8. Inufusa, H., Sagara, N., Takagi, H., Yamato, M., Hamada, H., Okuno, K., Iwasa, Z., and Yasutomi, M. Experimental measurement of a new tumor marker KM01 -comparative study with CA19-9, CEA and IPA-. J Jpn Soc Clin Surg, 47: 1568-1573, 1986.
9. Iwasa, Z., Inufusa, H., Takagi, H., Tanaka, A., Nakamura, T., Fukuhara, T., and Yasutomi, M. Immunohistochemical studies on estrogen receptor of gastric cancers. Jpn J Gastroenterol Surg, 19: 1706-1710, 1986.
10. Iwasa, Z., Matsunami, N., Takagi, H., Tanaka, A., Inufusa, H., Hamada, H., and Yasutomi, M. Immunohistochemical studies on estrogen receptors in gastric cancer by immunoperoxidase technique. Acta Med Kinki Univ, 11: 129-134, 1986.
11. Inufusa, H. Characterization and metastatic study in nude mouse of human lung adenocarcinoma cell line KUMLK-2. Med J Kinki Univ, 12: 631-641, 1987.
12. Okuno, K., Nakamura, Y., Takagi, H., Kokudo, S., Onishi, H., Inufusa, H., Nakamura, T., Tanaka, A., Hamada, H., Iwasa, Z., and Yasutomi, M. Surface antigen analysis and anti-tumor activity of peritoneal exudate cells in the patients with gastric cancer and their modulating effect of OK432 pretreatment. Jpn J Gastroenterol Surg, 20: 1017-1021, 1987.
13. Sagara, N., Inufusa, H., Onishi, H., Haeno, Y., Hara, S., Kurooka, K., Kayama, H., and Yasutomi, M. Diagnostic value of tumor markers and combination assay with CEA, IAP, CA19-9, KM01 and CSLEX-1 for gastroenterological disease. Med J Kinki Univ, 11: 453-458, 1987.
14. Tanaka, A., Inufusa, H., Takagi, H., Hatta, M., Nakamura, T., Hamada, H., Izumoto, G., Iwasa, Z., and Yasutomi, M. Studies on the lymph node metastasis of gastric cancer and the sinus histiocytosis of lymph node by the clearing method. Jpn J Gastroenterol Surg, 20: 1837-1843, 1987.
15. Hamada, H., Tanaka, A., Takagi, H., Mori, N., Nakamura, Y., Inufusa, H., Nakamura, T., Shindo, K., and Yasutomi, M. A case report of disappearance of liver metastasis from gastric carcinoma treated with intra-arterial chemotherapy combined with OK-432. Med J Kiniki Univ, 13: 203-210, 1988.
16. Inufusa, H., Sagara, N., Nakano, K., Aizawa, M., and Yasutomi, M. Platelet aggregating activity and metastatic remission of human lung adenocarcinoma cell line KUMLK-2. Blood and Vessel, 19: 280-282, 1988.
17. Inufusa, H., Sagara, N., and Yasutomi, M. Characterization of the platelet aggregating material extracted from human lung cancer cell line which produce spontaneous lung metastasis in nude mice subcutaneous implantation. Blood and Vessel, 19: 283-286, 1988.
18. Inufusa, H. Establishment and characterization of human lung adenocarcinoma cell line KUM,LK-2 which produce spontaneous lung metastasis by nude mice subcutaneous implantation. J Jpn Surg Soc, 89: 1075-1082, 1988.
19. Mori, N., Inufusa, H., Aizawa, M., Nakano, K., Nakamura, Y., Nakamura, T., Hamada, H., Sagara, N., and Yasutomi, M. Experiences in measurement of tumor marker KM01-EIA, A comparative study with KM01-RPHA and CA19-9. Jpn J Gastroenterol Surg, 21: 2406-2410, 1988.
20. Sagara, N., Nakano, K., Aizawa, M., Hara, S., Inufusa, H., Mori, N., Kurooka, K., Haeno, Y., and Yasutomi, M. Influence of fosfomycin combination on anti-tumor effect of CDDP. Jpn J Cancer Chemother, 15: 94-100, 1988.
21. Sagara, N., Inufusa, H., Nakano, K., Hara, S., Aizawa, M., Kurooka, K., Haeno, Y., and Yasutomi, M. Tissue plasminogen activator and the development of spontaneous lung metastasis in nude mice hosts of transplanted human lung cancer cells. Lung Cancer, 28: 843-847, 1988.
22. Dohi, T., Nores, G. A., H.Oguchi, Inufusa, H., and Hakomori, S.-i. GM3 lactone as an immunogen associate with melanoma: Effect of immunization with GM3 lactone on melanoma growth in vivo. In: Gangliosides and cancer, pp. 273-282. New York: VCH publisher, 1989.
23. Inufusa, H., Sagara, N., Yasutomi, M., and Matsuo, O. Absence of t-PA in spontaneous metastatic lesions induced by a newly established cell line. Thrombosis Research, 53: 395-400, 1989.
24. Nakano, K., Sagara, N., Inufusa, H., Aizawa, M., Hara, S., Mori, N., and Yasutomi, M. The effect of blood transfusion on tumor growth and metastasis formation -a nude mouse-human cancer cell model-. Human Cell, 2: 304-306, 1989.
25. Sagara, N., Inufusa, H., Nakano, K., Mori, N., Aizawa, M., Hara, S., Hirohata, K., and Yasutomi, M. Establishment and characterization of human lung cancer cell line KUMLK-2. Human Cell, 2: 397-399, 1989.
26. Mori, N., Sagara, N., Hara, S., Inufusa, H., and Yasutomi, M. Procoagulant activity of human cancer cell line. Japanese Journal of Thrombosis and Haemostasis, 1: 553-555, 1990.
27. Adachi, T., Inufusa, H., Mori, N., Hara, S., Sagara, N., Matsuda, T., and Yasutomi, M. Characterization and metastatic potential of a mouse adenocarcinoma cell line XK-4 which arose in nude mouse during the transplantation of human colon cancer cell line KUM.RK-4N. Jpn J Gastroenterol Surg, 24: 2982-2989, 1991.
28. Inufusa, H., Kojima, N., Yasutomi, M., and Hakomori, S.-i. Human lung adenocarcinoma cell lines with different lung colonization potential(LCP), and a correlation between expression of sialosyl dimeric Lex(defined by MAb FH6) and LCP. Clin.Expl.Metastasis, 9: 245-257, 1991.
29. Yasutomi, M., Inufusa, H., Hida, J., and Matsuda, T. Surgery for cancer of anal and anal canal. Operation, 45: 1481-1486, 1991.
30. Adachi, T. and Inufusa, H. Inhibition of liver metastasis of a adenocarcinoma using YIGSR and synthetic polypeptide -polymeric star burst YIGSR-. Med J Kinki Univ, 17: 83-94, 1992.
31. Hagiya, Y., Fukao, M., Ueshima, S., Izaki, S., Inufusa, H., Kamiishi, H., Okada, K., and Matsuo, O. Urokinase-type plasminogen activator and its specific receptor in high metastatic and non-metastatic cell lines derived a human lung adenocarcinoma. Thrombosis Res., 65: 449-456, 1992.
32. Inufusa, H., Hara, S., Mori, N., and Yasutomi, M. Establishment and characterization of a human squamous cell carcinoma cell line LK-52 which produce direct activator of coagulant factor X. Human Cell, 5: 287-291, 1992.
33. Yasutomi, M., Inufusa, H., and Shindo, K. Diagnosis and therapy for the recto-proctal disease 1. symptoms, pathogenesis and examination. Surgical Therapy, 66: 718-722, 1992.
34. Inufusa, H. Pathway and prevention of metastasis in colo-rectal cancer. Jpn J Clin Nursing, 19: 1052-1056, 1993.
35. Inufusa, H., Adachi, T., Suzuki, M., Kurimoto, M., and Yasutomi, M. Generation of monoclonal antibodies against a novel coagulant cancer antigen 1 (CCA-1) and it's expression on human cancer cell lines. Jpn J Thromb Haemost, 4: 232-236, 1993.
36. Inufusa, H., Adachi, T., Nakamura, M., Shindo, K., and Yasutomi, M. Expression of a novel cancer antigen coagulant cancer antigen 1 (CCA-1) on various human cancers: preliminary report. J Jpn Surg Soc, 94: 1166, 1993.
37. Inufusa, H., Adachi, T., Mori, N., Nakamura, M., Hara, S., Shindo, K., Yasutomi, M., and Sasaki, T. Enhanced inhibitory effect of polymeric star burst formed YIGSR peptide on newly established nude mouse spontaneous adenocarcinoma metastatic model. Int J Oncology, 3, 1993.
38. Inufusa, H., Adachi, T., Nakamura, M., Shindo, K., and Yasutomi, M. Expression of a novel cancer antigen coagulant cancer antigen 1 on colorectal cancers. Jpn J Gastroenterol Surg, 26: 2809-2815, 1993.
39. Inufusa, H. New procoagulant activity of coagulant cancer antigen 1 which defined on cancer cell surface. Jpn J Thromb Haemost, 4: 448-451, 1993.
40. Kinoshita, T., Inufusa, H., Morikawa, E., Kitaoka, M., Nakamura, M., Nagayama, K., Akabane, Y., Adachi, T., Shindo, K., and Yasutomi, M. A case report of a mucocele of the appendix with intussusception. Med J Kinki Univ, 18: 457-463, 1993.
41. Mori, N., Inufusa, H., Adachi, T., Hara, S., Sagara, N., and Yasutomi, M. Establishment of a human lung squamous cell carcinoma cell line LK-17, and characterization of procoagulant, platelet aggregation and metastatic potential. Human Cell, 6: 226-230, 1993.
42. Son, E., Inufusa, H., Nakamura, M., Kitaoka, M., Adachi, T., Akabane, Y., Morikawa, E., Shindo, K., and Yasutomi, M. A case report of enterocutaneous fistula due to appendectomy 22 years after surgery. Med J Kinki Univ, 18: 315-318, 1993.
43. Yasutomi, M. and Inufusa, H. Revision of general rules for clinical and pathological studies on cancer of the colon, rectum and anus. In: Practical Gastroenterology 5, pp. 185-189. Tokyo: Bunkodo, 1993.
44. Funai, S., Kurooka, K., Fujii, Y., Inufusa, H., Yamada, H., Imanishi, Y., Sato, S., Shindo, K., and Yasutomi, M. MultiCycleTM software for cell cycle analysis. Jpn J Cancer Chemother, 21: 102-107, 1994.
45. Morikawa, E., Yasutomi, M., Shindo, K., Matsuda, T., Mori, N., Hida, J., Kubo, R., Kitaoka, M., Nakamura, M., Fujimoto, K., Inufusa, H., Hatta, M., and Izumoto, G. Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum, 37: 219-223, 1994.
46. Nakamura, M. and Inufusa, H. Role of laminin-binding lectin CBP35 in colorectal cancer liver metastasis. Med J Kinki Univ, 19: 537-551, 1994.
47. Nakamura, M., Inufusa, H., Adachi, T., Shindo, K., Yasutomi, M., and Matsuura, H. Expression of oncofetal and normal fibronectin in colorectal cancer -correlation with stage, liver metastasis and prognosis-. Jpn J Gastroenterol Surg, 27: 884-891, 1994.
48. Nakamura, M., Inufusa, H., Adachi, T., Shindo, K., and Yasutomi, M. Expression of laminin-binding lectin CBP35 in colorectal cancer: correlation with liver metastasis. Jpn J Gastroenterol, 91: 1272, 1994.
49. Adachi, T., Inufusa, H., Nakatani, Y., Nakamura, M., Funai, S., Shindo, K., and Yasutomi, M. Roll of the tissue factor and coagulant cancer antigen 1 in the procoagulant activity of colorectal cancer cell line. Jpn J Gastroenterol Surg, 28: 977, 1995.
50. Inufusa, H., Nakamura, M., Adachi, T., Nakatani, Y., Shindo, K., Yasutomi, M., and Matsuura, H. Localization of oncofetal and normal fibronectin in colorectal cancer. Cancer, 75: 2802-2808, 1995.
51. Inufusa, H., Adachi, T., Nakamura, M., Shindo, K., Yasutomi, M., and Kimura, Y. Inhibition of experimental metastasis of human adenocarcinoma by cilostazol, a platelet phosphodiesterase inhibitor. Oncology Report, 2: 1079-1083, 1995.
52. Kubo, R., Machidera, N., Fujimoto, K., Ieda, S., Hida, J., Inufusa, H., Watatani, M., Shindo, K., and Yasutomi, M. Adjuvant therapy of colorectal carcinoma. Surgical Therapy, 73: 65-69, 1995.
53. Watatani, M., Tokoro, T., Machidera, N., Ieda, S., Fujimoto, K., Hida, J., Kubo, R., Inufusa, H., Shindo, K., and Yasutomi, M. Management of early colorectal cancer. Gastroenterol Surg, 18: 739-744, 1995.
54. Watatani, M., Kitaoka, M., Kuroda, K., Kubo, R., Machidera, N., Ieda, S., Fujimoto, K., Hida, J., Inufusa, H., and Yasutomi, M. Prognostic predictors in colorectal cancer. Jpn J Cancer Chemother, 22: 1129-1134, 1995.
55. Watatani, M., Nishimura, K., Ieda, S., Fujimoto, K., Hida, J., Kubo, R., Inufusa, H., and Yasutomi, M. Control of patient one week after the surgery, colon resection. Clinical Surgery, 50: 118-122, 1995.
56. Hagiya, Y., Fukao, H., Ueshima, S., Okada, K., Inufusa, H., Kamiishi, H., and Matsuo, O. Enhanced urokinase-type plasminogen activator activity by extracellular matrix protein obtained from highly metastatic human lung adenocarcinoma cell line. Clinca Chimica Acta, 253: 37-50, 1996.
57. Hida, J.-i., Yasutomi, M., Shindo, K., Kitaoka, M., Fujimoto, K., Ieda, S., Machidera, N., Kubo, R., MOrikawa, E., Inufusa, H., Watatani, M., and Okuno, K. Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques. Dis Colon Rectum, 39: 74-79, 1996.
58. Inufusa, H. Malignant tumor and thrombosis-Mechanisms- Procoagulant. Thrombosis and Circulation, 4: 278-282, 1996.
59. Nakatani, Y., Inufusa, H., Hida, J.-i., Nakamura, T., and Yasutomi, M. A case of gas-producing liver abscess with sepsis. J Jpn Soc Clin Surg, 57: 145-149, 1996.
60. Nakatani, Y., Inufusa, H., Adachi, T., Nakamura, M., and Yasutomi, M. Role of tissue factor and coagulant cancer antigen 1 in the procoagulant activity of breast cancer cell line. Jpn J Thromb Haemost, 7: 451-456, 1996.
61. Adachi, T., Inufusa, H., Nakatani, Y., Wakano, T., and Yasutomi, M. Role of coagulant cancer antigen 1, tissue factor and HLA-DR in the procoagulant activity of human gastric cancer cell line. Jpn J Gastroenterol, 94: 513, 1997.
62. Huang, C.-L., Taki, T., Adachi, M., Yagita, M., Sawada, S., Takabayashi, A., Inufusa, H., Yoshie, O., and Miyake, M. MRP-1/CD9 and KA11/CD82 expression in normal and various cancer tissues. International Journal of Oncology, 11: 1045-1051, 1997.
63. Nakatani, Y., Inufusa, H., and Adachi, T. Correlation between expression of coagulant cancer antigen 1 and prognosis of breast cancer patients. J Jpn Soc Cancer Ther, 32: 271-281, 1997.
64. Suzuki, M., Inufusa, H., Yamamoto, S., Hamada, T., Aga, M., Ando, O., Ohta, T., Yasutomi, M., and Kurimoto, M. Ley glycolipid acts as a co-factor for a tumor procoagulant activity. Int J Cancer, 73: 903-909, 1997.
65. Hashimoto, Y., Inufusa, H., Adachi, T., Funai, S., Wakano, T., Nakajima, A., Shindo, K., and Yasutomi, M. Ley expression and procoagulant activity of pancreas cancer cell line MIAPaCa-II induced by apoptosis. Jpn J Gastroenterol Surg, 31: 2181, 1998.
66. Hida, J.-i., Yasutomi, M., Maruyama, T., Wakano, T., Uchida, T., Fujimoto, K., Kubo, R., Inufusa, H., Uemura, H., and Shindo, K. Anterior resection following transsacral stapling and transection of the anal canal for low-lying rectal cancer in males. Surgery Today, 28: 768-769, 1998.
67. Inufusa, H., Adachi, T., Suzuki, M., Ando, O., Ohta, T., Kurimoto, M., Nakatani, Y., Nakamura, M., and Shindo, K. Generation of a monoclonal antibody that inhibits the procoagulant activity of various cancer cell lines. Cancer, 82: 1563-1569, 1998.
68. Inufusa, H., Nakatani, Y., Adachi, T., Wakano, T., Nakajima, A., Nakamura, M., Suzuki, M., Ando, O., Kurimoto, M., Miyake, M., Shindo, K., and Yasutomi, M. Correlation of prognosis of breast cancer patients and expression of Ley which acts as a cofactor of tumor procoagulant. International Journal of Oncology, 13: 481-487, 1998.
69. Wakano, T., Inufusa, H., Nkajima, A., Fujimoto, K., Hida, J.-i., Shindo, K., and Yasutomi, M. A case of simple ulcer of caecum which showed elevated lesion. Med J Kinki Univ, 23: 227-230, 1998.
70. Huang, C.-l., Kohno, N., Inufusa, H., Kodama, K., Taki, T., and Miyake, M. Overexpression of bax associated with Mutations in the loop-sheet-helix motif of p53. Am J Patology, 155: 955-965, 1999.
71. Inufusa, H., Kayama, H., and Yasutomi, M. Technique of laparoscopic surgery for colorectal cancer. Gastroenterological Surgery (Shokakigeka), 22: 163-171, 1999.
72. Inui, H., Inufusa, H., Watatani, M., and Yasutomi, M. Laparoscopic surgery of birateral adrenalectomy for birateral pheochromocytoma of MEN IIa. Operation (Shujutu), 6: 813-816, 1999.
73. Nakamura, M., Inufusa, H., Adachi, T., Aga, M., Kurimoto, M., Nakatani, Y., Wakano, T., Nakajima, A., Hida, J.-i., Miyake, M., Shindo, K., and Yasutomi, M. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol, 15: 143-148, 1999.
74. Suzuki, M., Ando, O., Ohta, T., Inufusa, H., Adachi, T., Yasutomi, M., and Kurimoto, M. High expression of glycosphingolipids involved in procoagulant activity of cancer cells. Oncology Report, 6: 113-115, 1999.
75. Huang, C.-l., Kohno, N., Inufusa, H., Kodama, K., Taki, T., and Miyake, M. Overexpression of bax associated with Mutations in the loop-sheet-helix motif of p53. Am J Patology, 155: 955-965, 1999.
76. Nakamura, M., Inufusa, H., Adachi, T., Aga, M., Kurimoto, M., Nakatani, Y., Wakano, T., Nakajima, A., Hida, J.-i., Miyake, M., Shindo, K., and Yasutomi, M. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol, 15: 143-148, 1999.
77. Inufusa, H., Hitoshi, K. and Yasutomi, M. Technique of laparoscopic surgery for colorectal cancer. Gastroenterological Surgery, 22: 163-171, 1999.
78. Wakano, T., Inufusa, H., Adachi, T., and Nakatani, Y. Regulation of Lewis Y expression by transforming growth factor-ß1and blood coagulating activity in colorectal cancer. Med J Kinki Univ, 24: 283-291, 1999.
79. Adachi, M., Taki, T., Higashiyama, M., Kohno, N., Inufusa, H., and Miyake, M. Significance of Integlin a5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clinical Cancer Research, 6: 96-101, 2000.
80. Fukao, H., Ikeda, M., Ichikawa, T., Inufusa, H., Okada, K., Ueshima, S., and Matsuo, O. Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines. Clin Chim Acta., 296: 17-33, 2000.
81. Konishi, T., Huang, C.-L., Adachi, M., Taki, T., Inufusa, H., Kodama, K., Kohno, N., and Miyake, M. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancer. International Journal of Oncology, 16: 501-511, 2000.
82. Miyake, M., Inufusa, H., Adachi, M., Ishida, H., Hashida, H., Tokuhara, T., and Kakehi, Y. Suppression of pulmonary metastasis using adenovirally motility related protein (MRP1/CD9) gene delivery. Oncogene, 19: 5221-5226, 2000.
83. Inufusa, H., Ueda, K., Kawabe, T., and Yasutomi, M. New Wound Protector for Laparoscopic Colorectal Surgery. Journal of Japan society for endoscopic surgery, 5: 361-363, 2000.
84. Inufusa, H., Adachi, T., Nakatani, Y., Wakano, T., Nakamura, M., Okuno, K., Shiozaki, H., Yamamoto, S., Suzuki, M., Ando, O., Kurimoto, M., Miyake, M., and Yasutomi, M. Ley glycolipid-recognizing monoclonal antibody inhibits procoagulant activity and metastasis of human adenocarcinoma. Int J Oncol, 19:941-946, 2001.
85. Inufusa, H., Nakamura, M., Adachi, T., Aga, M., Kurimoto, M., Nakatani, Y., Wakano, T., Miyake, M., Okuno, K., Shiozaki, H., and Yasutomi, M. Role of Galectin-3 in Adenocarcinoma Liver Metastasis. Int J Oncol, 19:913-919, 2001